User:JonSDSUGrad/Sandbox/TEST7 TGFB1
From Wikipedia, the free encyclopedia
[edit] Summary
TGFB is a multifunctional peptide that controls proliferation, differentiation, and other functions in many cell types. TGFB acts synergistically with TGFA (MIM 190170) in inducing transformation. It also acts as a negative autocrine growth factor. Dysregulation of TGFB activation and signaling may result in apoptosis. Many cells synthesize TGFB and almost all of them have specific receptors for this peptide. TGFB1, TGFB2 (MIM 190220), and TGFB3 (MIM 190230) all function through the same receptor signaling systems.[supplied by OMIM][1]
[edit] References
- ^ Entrez Gene: TGFB1 transforming growth factor, beta 1. Retrieved on 2007-08-07.
[edit] Further reading
- Border WA, Noble NA (1994). "Transforming growth factor beta in tissue fibrosis.". The New England journal of medicine 331 (19): 1286-92. PMID 7935686.
- Munger JS, Harpel JG, Gleizes PE, Mazzieri R, Nunes I, Rifkin DB (1997). "Latent transforming growth factor-beta: structural features and mechanisms of activation.". Kidney international 51 (5): 1376-82. PMID 9150447.
- Iozzo RV (1999). "The biology of the small leucine-rich proteoglycans. Functional network of interactive proteins.". The Journal of biological chemistry 274 (27): 18843-6. PMID 10383378.
- Reinhold D, Wrenger S, Kähne T, Ansorge S (1999). "HIV-1 Tat: immunosuppression via TGF-beta1 induction.". Immunology today 20 (8): 384-5. PMID 10431160.
- Yamada Y (2002). "Association of polymorphisms of the transforming growth factor-beta1 gene with genetic susceptibility to osteoporosis.". Pharmacogenetics 11 (9): 765-71. PMID 11740340.
- Chen W, Wahl SM (2002). "TGF-beta: receptors, signaling pathways and autoimmunity.". Current directions in autoimmunity 5: 62-91. PMID 11826761.
- Marone M, Bonanno G, Rutella S, Leone G, Scambia G, Pierelli L (2003). "Survival and cell cycle control in early hematopoiesis: role of bcl-2, and the cyclin dependent kinase inhibitors P27 and P21.". Leukemia & lymphoma 43 (1): 51-7. PMID 11908736.
- Schnaper HW, Hayashida T, Hubchak SC, Poncelet AC (2003). "TGF-beta signal transduction and mesangial cell fibrogenesis.". American journal of physiology. Renal physiology 284 (2): F243-52. doi:. PMID 12529270.
- Kalluri R, Neilson EG (2004). "Epithelial-mesenchymal transition and its implications for fibrosis.". The Journal of clinical investigation 112 (12): 1776-84. doi:. PMID 14679171.
- Grainger DJ (2005). "Transforming growth factor beta and atherosclerosis: so far, so good for the protective cytokine hypothesis.". Arteriosclerosis, thrombosis, and vascular biology 24 (3): 399-404. doi:. PMID 14699019.
- Attisano L, Labbé E (2004). "TGFbeta and Wnt pathway cross-talk.". Cancer metastasis reviews 23 (1-2): 53-61. PMID 15000149.
- McGowan TA, Zhu Y, Sharma K (2005). "Transforming growth factor-beta: a clinical target for the treatment of diabetic nephropathy.". Current diabetes reports 4 (6): 447-54. PMID 15539010.
- Sheppard D (2006). "Integrin-mediated activation of latent transforming growth factor beta.". Cancer metastasis reviews 24 (3): 395-402. doi:. PMID 16258727.
- Gressner AM, Weiskirchen R (2006). "Modern pathogenetic concepts of liver fibrosis suggest stellate cells and TGF-beta as major players and therapeutic targets.". Journal of cellular and molecular medicine 10 (1): 76-99. PMID 16563223.
- Seoane J (2006). "Escaping from the TGFbeta anti-proliferative control.". Carcinogenesis 27 (11): 2148-56. doi:. PMID 16698802.
- Lee CG, Kang HR, Homer RJ, Chupp G, Elias JA (2006). "Transgenic modeling of transforming growth factor-beta(1): role of apoptosis in fibrosis and alveolar remodeling.". Proceedings of the American Thoracic Society 3 (5): 418-23. doi:. PMID 16799085.
- Wahl SM (2007). "Transforming growth factor-beta: innately bipolar.". Current opinion in immunology 19 (1): 55-62. doi:. PMID 17137775.

